I agree totally ABTech platform is great IMO.Management and...

I agree totally AB
Tech platform is great IMO.
Management and Board is dreadful - Again IMO
AZ was a red herring - Recent Dep Dox results showed how good the platform is in solid tumors (look at the intertumoral concentrations). Question has to be why lift everyones hope on blood borne. Did they not understand the tech? (Yes I understand neutropenia but in solid tumors the environment gives rise to the enzymatic cleaving of the chemotherapeutic agent that you wont find in blood)
Any why keep testing the drug in cancers that the original drug isn't specified. Never going to be used that way. Need to replace where the original drug is used. Head to head baby!!!!
They have wasted many years and a lot of shareholder capital.

BTW from a bystander point of view you guys need to stop measuring appendages. Less ramp (both ways) and less who made what etc. More about the science and what can be done to fix this seriously undervalued company. First step for me would have to get rid of the Chair that has overseen this disaster. Seriously disappointing vote against. Finally the DepDox trial I wanted to see a lot more tabulated data, rather than the headline info they provided, Viraleze, the trial is a joke and Vivagel, mgt need to come clean on the FDA interactions.

This stock would be seriously higher if in the right hands